0.46

8.40% -0.04

Co Diagnostics Inc (CODX)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione

Precedente Chiudi:

$0.50

Aprire:

$0.5

Volume 24 ore:

191.83K

Relative Volume:

0.97

Capitalizzazione di mercato:

$15.97M

Reddito:

$7.11M

Utile/perdita netta:

$-41.28M

Rapporto P/E:

-0.3333

EPS:

-1.38

Flusso di cassa netto:

$-26.84M

1 W Prestazione:

-10.84%

1M Prestazione:

-33.62%

6M Prestazione:

-65.04%

1 anno Prestazione:

-61.19%

Intervallo 1D:

$0.45

$0.5297

Intervallo di 1 settimana:

$0.45

$0.6764

Portata 52W:

$0.45

$2.2299

Co Diagnostics Inc Stock (CODX) Company Profile

Nome

Co Diagnostics Inc

Settore

Healthcare (1172)

Industria

Medical Devices (161)

Telefono

(801) 278-9769

Indirizzo

4049 SOUTH HIGHLAND DRIVE, SALT LAKE CITY

Dipendente

155

Cinguettio

@Co_Diagnostics

Prossima data di guadagno

2024-11-07

Ultimi documenti SEC

CODX's Discussions on Twitter

Confronta CODX con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
CODX Co Diagnostics Inc	0.4974	15.97M	7.11M	-41.28M	-26.84M	-1.38
ABT Abbott Laboratories	130.35	225.41B	41.95B	13.40B	6.35B	7.65
BSX Boston Scientific Corp	95.29	140.36B	16.75B	1.85B	2.37B	1.25
SYK Stryker Corp	361.71	138.70B	22.60B	2.99B	3.49B	7.76
MDT Medtronic Plc	92.23	118.30B	33.20B	4.26B	5.47B	3.29
EW Edwards Lifesciences Corp	67.56	39.77B	5.72B	4.17B	259.90M	6.97

Co Diagnostics Inc Stock (CODX) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2022-08-12	Downgrade	Sidoti	Buy → Neutral
2021-12-29	Iniziato	Sidoti	Buy
2021-03-29	Downgrade	Maxim Group	Buy → Hold
2020-05-20	Aggiornamento	Maxim Group	Hold → Buy
2020-05-18	Reiterato	H.C. Wainwright	Buy
2020-03-09	Reiterato	H.C. Wainwright	Buy
2020-03-03	Downgrade	Maxim Group	Buy → Hold

Mostra tutto

Co Diagnostics Inc Borsa (CODX) Ultime notizie

11:14 AM

Co-Diagnostics, Inc. Announces Fourth Quarter and Full Year 2024 Earnings Release Date and Webcast - BioSpace

11:14 AM

09:30 AM

Co-Diagnostics Sets Date for Crucial Year-End 2024 Financial Results - StockTitan

09:30 AM

Mar 11, 2025

Co-Diagnostics Inc.’s Securities Class Action - Global Legal Chronicle

Mar 11, 2025

Mar 10, 2025

Co-Diagnostics Inc expected to post a loss of 34 cents a shareEarnings Preview - TradingView

Mar 10, 2025

Mar 06, 2025

Co-Diagnostics wins dismissal of class action lawsuit - TipRanks

Mar 06, 2025

Federal Court Validates Co-Diagnostics' COVID Test ClaimsWhat This Legal Win Means - StockTitan

Mar 06, 2025

Co-Diagnostics (CODX) Projected to Post Earnings on Thursday - Defense World

Mar 06, 2025

Mar 05, 2025

Analyzing ResMed (NYSE:RMD) and Co-Diagnostics (NASDAQ:CODX) - Defense World

Mar 05, 2025

Mar 03, 2025

Co-Diagnostics stock hits 52-week low at $0.49 amid market challenges - Investing.com Australia

Mar 03, 2025

Co-Diagnostics stock hits 52-week low at $0.49 amid market challenges By Investing.com - Investing.com South Africa

Mar 03, 2025

Co-Diagnostics, Inc. and CoSara to Host HPV and Cancer Symposium on International HPV Day 2025 - PR Newswire

Mar 03, 2025

Feb 26, 2025

Comparing Globus Medical (NYSE:GMED) and Co-Diagnostics (NASDAQ:CODX) - Defense World

Feb 26, 2025

Feb 24, 2025

Co-Diagnostics stock hits 52-week low at $0.65 amid market challenges - Investing.com Australia

Feb 24, 2025

Co-Diagnostics stock hits 52-week low at $0.65 amid market challenges By Investing.com - Investing.com South Africa

Feb 24, 2025

Penny Stock Co-Diagnostics Withdraws FDA Application For COVID-19 Test, Plans To Submit Enhanced Version - Yahoo Finance

Feb 24, 2025

Infectious Disease Diagnostics Market (2024-2035): Trends, Growth Drivers, and Future Outlook - PharmiWeb.com

Feb 24, 2025

Looking For A Good Stock? Let This Co-Diagnostics Inc (NASDAQ: CODX) Analysis Help. - Stocks Register

Feb 24, 2025

Analyzing Co-Diagnostics (NASDAQ:CODX) and CVRx (NASDAQ:CVRX) - Defense World

Feb 24, 2025

Feb 22, 2025

CODX CLASS ACTION: Hagens Berman, National Trial Attorneys, Encourages Co-Diagnostics (CODX) Investors with Significant Losses to Contact the Firm’s Attorneys, Securities Fraud Class Action Filed - ACCESS Newswire

Feb 22, 2025

Co-Dx withdraws FDA application to update COVID-19 test By Investing.com - Investing.com Australia

Feb 22, 2025

Feb 21, 2025

Co-Diagnostics Announces Intention To Submit Enhanced Version Of Covid-19 Test To FDA - Marketscreener.com

Feb 21, 2025

Co-Diagnostics Plans to Seek FDA Clearance for Enhanced Version of COVID-19 Test - Marketscreener.com

Feb 21, 2025

Co-Diagnostics Withdraws FDA Application for Covid Test -February 21, 2025 at 04:48 pm EST - Marketscreener.com

Feb 21, 2025

Co-Dx withdraws FDA application to update COVID-19 test - Investing.com India

Feb 21, 2025

Co-Diagnostics, Inc. Announces Intention to Submit Enhanced Version of COVID-19 Test to FDA for 510(k) Clearance - WV News

Feb 21, 2025

Co-Diagnostics (CODX) Stock Price, News & Analysis - MarketBeat

Feb 21, 2025

Feb 17, 2025